{"id":187,"date":"2017-12-12T00:00:00","date_gmt":"2017-12-11T23:00:00","guid":{"rendered":"http:\/\/idlbiotech.com\/?p=187"},"modified":"2021-05-26T10:22:32","modified_gmt":"2021-05-26T08:22:32","slug":"hello-world-2","status":"publish","type":"post","link":"https:\/\/idldiagnostics.com\/se\/2017\/12\/12\/hello-world-2\/","title":{"rendered":"Positiva resultat f\u00f6r TPS\u00ae"},"content":{"rendered":"

Resultat fr\u00e5n en tjeckisk studie.<\/p>\n

Br\u00f6stcancer utg\u00f6r 24 % av all cancer som drabbar kvinnor. Br\u00f6stcancer \u00e4r den vanligaste maligniteten och den n\u00e4st vanligaste d\u00f6dsorsaken av cancer hos kvinnor. Trots att incidensen av br\u00f6stcancer har \u00f6kat har d\u00f6dligheten f\u00f6rblivit stabil under \u00e5rtionden. Detta beror s\u00e4rskilt p\u00e5 tidigare diagnos och ett effektivt screeningprogram samt framsteg inom behandling.<\/p>\n

Denna studie, publicerad i Anticancer Research (Svobodova et al. 2018), genomf\u00f6rdes vid University Hospital and Faculty of Medicine, Charles University Pilsen. Syftet med studien var att f\u00f6ruts\u00e4ga \u00e5terfall hos patienter med br\u00f6stcancer, n\u00e4r m\u00e4tning av biomark\u00f6rer utf\u00f6rs inom 1 till 6 m\u00e5nader efter operation. I denna studie utv\u00e4rderades tre olika biomark\u00f6rer; TPS\u00ae<\/sup> (v\u00e4vnadspolypeptid-specifikt antigen), CEA och CA 15-3.<\/p>\n

Den genererade datan visar att TPS\u00ae<\/sup> patienternas niv\u00e5er i \u00e5terfallsgruppen skilde sig statistiskt signifikant under f\u00f6rsta och sj\u00e4tte m\u00e5naden efter operation j\u00e4mf\u00f6rt med patienterna i den \u00e5terfallsfria gruppen. CEA- och CA 15-3-m\u00e4tningar uppn\u00e5dde ingen statistiskt signifikant skillnad f\u00f6r n\u00e5gon av de unders\u00f6kta m\u00e5naderna.<\/p>\n

Fr\u00e5n de rapporterade uppgifterna drog man slutsatsen att TPS\u00ae<\/sup> niv\u00e5n som m\u00e4ts under den sj\u00e4tte m\u00e5naden efter operation \u00e4r den b\u00e4sta biomark\u00f6ren f\u00f6r att f\u00f6ruts\u00e4ga \u00e5terfall av sjukdomen. F\u00f6rfattarna f\u00f6resl\u00e5r att TPS\u00ae b\u00f6r l\u00e4ggas till panelen med biomark\u00f6rer f\u00f6r uppf\u00f6ljnings\u00f6vervakning av br\u00f6stcancerpatienter efter operation.<\/p>\n

Om TPS\u00ae<\/sup><\/p>\n

Tum\u00f6rmark\u00f6ren TPS\u00ae<\/sup> \u00e4r en tillf\u00f6rlitlig indikator p\u00e5 tum\u00f6rcellers aktivitet och \u00e4r s\u00e4rskilt anv\u00e4ndbar vid patienthantering f\u00f6r olika karcinom. J\u00e4mf\u00f6rt med konventionella tum\u00f6rmassmark\u00f6rer, aktivitetssmark\u00f6ren TPS\u00ae<\/sup> ger klinikern tidigare signaler om sjukdomsf\u00f6rloppet. TPS\u00ae<\/sup> \u00e4r s\u00e4rskilt anv\u00e4ndbart vid behandlingsuppf\u00f6ljning och \u00f6vervakning av patienter med epitelcellscancer t.ex. br\u00f6st-, prostata- och \u00e4ggstockscancer.<\/p>\n

TPS\u00ae<\/sup> \u00e4r v\u00e4ldokumenterad och anv\u00e4nds rutinm\u00e4ssigt i Kina, Tjeckien, Sydkorea, Tyskland, Italien och \u00d6sterrike bland annat.<\/p>","protected":false},"excerpt":{"rendered":"

Results from a Czech Republic study. Breast cancer represents 24 % of all cancer occurring in women. Breast cancer is the most common malignancy and the second most frequent cause of death by cancer in women. Although the incidence rate of breast cancer has been increasing, the mortality rate has remained stable for decades. This […]<\/p>\n","protected":false},"author":1,"featured_media":2495,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[36],"tags":[],"dipi_cpt_category":[],"class_list":["post-187","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-breast-cancer-health-information"],"yoast_head":"\nPositive results for TPS\u00ae - IDL Diagnostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/idldiagnostics.com\/se\/2017\/12\/12\/hello-world-2\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Positive results for TPS\u00ae - IDL Diagnostics\" \/>\n<meta property=\"og:description\" content=\"Results from a Czech Republic study. Breast cancer represents 24 % of all cancer occurring in women. Breast cancer is the most common malignancy and the second most frequent cause of death by cancer in women. Although the incidence rate of breast cancer has been increasing, the mortality rate has remained stable for decades. This […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/idldiagnostics.com\/se\/2017\/12\/12\/hello-world-2\/\" \/>\n<meta property=\"og:site_name\" content=\"IDL Diagnostics\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/arocell\" \/>\n<meta property=\"article:published_time\" content=\"2017-12-11T23:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-26T08:22:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/testart.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1160\" \/>\n\t<meta property=\"og:image:height\" content=\"623\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"insignjohan\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skriven av\" \/>\n\t<meta name=\"twitter:data1\" content=\"insignjohan\" \/>\n\t<meta name=\"twitter:label2\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2017\\\/12\\\/12\\\/hello-world-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2017\\\/12\\\/12\\\/hello-world-2\\\/\"},\"author\":{\"name\":\"insignjohan\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/person\\\/c53ef95aed85f62790948e1cc6b8cb70\"},\"headline\":\"Positive results for TPS\u00ae\",\"datePublished\":\"2017-12-11T23:00:00+00:00\",\"dateModified\":\"2021-05-26T08:22:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2017\\\/12\\\/12\\\/hello-world-2\\\/\"},\"wordCount\":332,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2017\\\/12\\\/12\\\/hello-world-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/testart.jpg\",\"articleSection\":[\"Breast Cancer\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/2017\\\/12\\\/12\\\/hello-world-2\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2017\\\/12\\\/12\\\/hello-world-2\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/2017\\\/12\\\/12\\\/hello-world-2\\\/\",\"name\":\"Positive results for TPS\u00ae - IDL Diagnostics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2017\\\/12\\\/12\\\/hello-world-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2017\\\/12\\\/12\\\/hello-world-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/testart.jpg\",\"datePublished\":\"2017-12-11T23:00:00+00:00\",\"dateModified\":\"2021-05-26T08:22:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2017\\\/12\\\/12\\\/hello-world-2\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/2017\\\/12\\\/12\\\/hello-world-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2017\\\/12\\\/12\\\/hello-world-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/testart.jpg\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2021\\\/05\\\/testart.jpg\",\"width\":1160,\"height\":623},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/2017\\\/12\\\/12\\\/hello-world-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Positive results for TPS\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#website\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"name\":\"IDL Diagnostics\",\"description\":\"Saving lives with diagnostics\",\"publisher\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/idldiagnostics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#organization\",\"name\":\"IDL Diagnostics\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"width\":1713,\"height\":570,\"caption\":\"IDL Diagnostics\"},\"image\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/arocell\",\"https:\\\/\\\/linkedin.com\\\/company\\\/arocell\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/#\\\/schema\\\/person\\\/c53ef95aed85f62790948e1cc6b8cb70\",\"name\":\"insignjohan\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/345758487c3b7ccd07f2b9a594ee9ec38f9f4a1bde6ba5316d5464403d76294b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/345758487c3b7ccd07f2b9a594ee9ec38f9f4a1bde6ba5316d5464403d76294b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/345758487c3b7ccd07f2b9a594ee9ec38f9f4a1bde6ba5316d5464403d76294b?s=96&d=mm&r=g\",\"caption\":\"insignjohan\"},\"sameAs\":[\"https:\\\/\\\/idldiagnostics.com\"],\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/se\\\/author\\\/insignjohan\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Positive results for TPS\u00ae - IDL Diagnostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/idldiagnostics.com\/se\/2017\/12\/12\/hello-world-2\/","og_locale":"sv_SE","og_type":"article","og_title":"Positive results for TPS\u00ae - IDL Diagnostics","og_description":"Results from a Czech Republic study. Breast cancer represents 24 % of all cancer occurring in women. Breast cancer is the most common malignancy and the second most frequent cause of death by cancer in women. Although the incidence rate of breast cancer has been increasing, the mortality rate has remained stable for decades. This […]","og_url":"https:\/\/idldiagnostics.com\/se\/2017\/12\/12\/hello-world-2\/","og_site_name":"IDL Diagnostics","article_publisher":"https:\/\/www.facebook.com\/arocell","article_published_time":"2017-12-11T23:00:00+00:00","article_modified_time":"2021-05-26T08:22:32+00:00","og_image":[{"width":1160,"height":623,"url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/testart.jpg","type":"image\/jpeg"}],"author":"insignjohan","twitter_card":"summary_large_image","twitter_misc":{"Skriven av":"insignjohan","Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/idldiagnostics.com\/2017\/12\/12\/hello-world-2\/#article","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/2017\/12\/12\/hello-world-2\/"},"author":{"name":"insignjohan","@id":"https:\/\/idldiagnostics.com\/#\/schema\/person\/c53ef95aed85f62790948e1cc6b8cb70"},"headline":"Positive results for TPS\u00ae","datePublished":"2017-12-11T23:00:00+00:00","dateModified":"2021-05-26T08:22:32+00:00","mainEntityOfPage":{"@id":"https:\/\/idldiagnostics.com\/2017\/12\/12\/hello-world-2\/"},"wordCount":332,"commentCount":0,"publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"image":{"@id":"https:\/\/idldiagnostics.com\/2017\/12\/12\/hello-world-2\/#primaryimage"},"thumbnailUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/testart.jpg","articleSection":["Breast Cancer"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/idldiagnostics.com\/2017\/12\/12\/hello-world-2\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/idldiagnostics.com\/2017\/12\/12\/hello-world-2\/","url":"https:\/\/idldiagnostics.com\/2017\/12\/12\/hello-world-2\/","name":"Positive results for TPS\u00ae - IDL Diagnostics","isPartOf":{"@id":"https:\/\/idldiagnostics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/idldiagnostics.com\/2017\/12\/12\/hello-world-2\/#primaryimage"},"image":{"@id":"https:\/\/idldiagnostics.com\/2017\/12\/12\/hello-world-2\/#primaryimage"},"thumbnailUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/testart.jpg","datePublished":"2017-12-11T23:00:00+00:00","dateModified":"2021-05-26T08:22:32+00:00","breadcrumb":{"@id":"https:\/\/idldiagnostics.com\/2017\/12\/12\/hello-world-2\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/idldiagnostics.com\/2017\/12\/12\/hello-world-2\/"]}]},{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/2017\/12\/12\/hello-world-2\/#primaryimage","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/testart.jpg","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2021\/05\/testart.jpg","width":1160,"height":623},{"@type":"BreadcrumbList","@id":"https:\/\/idldiagnostics.com\/2017\/12\/12\/hello-world-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/idldiagnostics.com\/"},{"@type":"ListItem","position":2,"name":"Positive results for TPS\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/idldiagnostics.com\/#website","url":"https:\/\/idldiagnostics.com\/","name":"IDL Diagnostik","description":"R\u00e4dda liv med diagnostik","publisher":{"@id":"https:\/\/idldiagnostics.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/idldiagnostics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/idldiagnostics.com\/#organization","name":"IDL Diagnostik","url":"https:\/\/idldiagnostics.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/","url":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","contentUrl":"https:\/\/idldiagnostics.com\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","width":1713,"height":570,"caption":"IDL Diagnostics"},"image":{"@id":"https:\/\/idldiagnostics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/arocell","https:\/\/linkedin.com\/company\/arocell"]},{"@type":"Person","@id":"https:\/\/idldiagnostics.com\/#\/schema\/person\/c53ef95aed85f62790948e1cc6b8cb70","name":"insignjohan","image":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/secure.gravatar.com\/avatar\/345758487c3b7ccd07f2b9a594ee9ec38f9f4a1bde6ba5316d5464403d76294b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/345758487c3b7ccd07f2b9a594ee9ec38f9f4a1bde6ba5316d5464403d76294b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/345758487c3b7ccd07f2b9a594ee9ec38f9f4a1bde6ba5316d5464403d76294b?s=96&d=mm&r=g","caption":"insignjohan"},"sameAs":["https:\/\/idldiagnostics.com"],"url":"https:\/\/idldiagnostics.com\/se\/author\/insignjohan\/"}]}},"_links":{"self":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/comments?post=187"}],"version-history":[{"count":2,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/187\/revisions"}],"predecessor-version":[{"id":2722,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/posts\/187\/revisions\/2722"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media\/2495"}],"wp:attachment":[{"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/media?parent=187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/categories?post=187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/tags?post=187"},{"taxonomy":"dipi_cpt_category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/se\/wp-json\/wp\/v2\/dipi_cpt_category?post=187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}